Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01778491 · ClinicalTrials.gov registry record
AMD Phenotype and Genotype Study
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 344
- Enrollment target
NCT01778491 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 344 participants.
The verdict
NCT01778491 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 344 participants
- Enrollment target
Study Summary
Background: \- Age-related macular degeneration (AMD) is a disease that blurs the sharp vision needed for activities such as reading, sewing, and driving. It affects the macula, the center of the retina at the back of the eye, which allows a person to see fine detail. Researchers want to collect medical histories, eye exam data, and genetic information that may be associated with AMD. They want to compare this information with information collected from people without AMD. Objectives: \- To collect medical information and gene samples for researchers studying AMD. Eligibility: * Individuals between and 60 and 90 years of age who have AMD in at least one eye. * Individuals between and 60 and 90 years of age who have no AMD in either eye. Design: * This study will involve one study visit. This study visit will last 6 to 8 hours. * Participants will have the following tests and exams as part of their study visit: * Full physical exam and medical history * Full eye examination * Laser scan of the eye * Retina function test * Vision sensitivity test * Optional blood sample (for genetic study) * No treatment will be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2012-11-05 |
| Est. Completion | 2015-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01778491
The ClinicalTrials.gov registry entry for NCT01778491 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01778491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01778491 about?
NCT01778491 is a clinical study titled "AMD Phenotype and Genotype Study". Background: \- Age-related macular degeneration (AMD) is a disease that blurs the sharp vision needed for activities such as reading, sewing, and driving. It affects the macula, the center of the retina at the back of the eye, which allows a person to see fine detail. Researchers want to collect me...
What is the current status of trial NCT01778491?
This trial is currently completed. The enrollment target is 344 participants. The study started on 2012-11-05. Estimated completion is 2015-09-29.
Who is sponsoring clinical trial NCT01778491?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.